Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis
This 2011 study by Cahill et al., published in the American Journal of Obstetrics and Gynecology, employed a decision-analytic and cost-effectiveness model to evaluate the use of magnesium sulfate (MgSO₄) for neuroprotection in women at risk of preterm birth before 32 weeks’ gestation. The model compared MgSO₄ therapy to no